Christine Coyne was appointed CCO at Iterum Therapeutics, which is launching ORLYNVAH™ in the US.
2 reports, 1 independent
Updated Jun 24
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Christine Coyne was appointed CCO at Iterum Therapeutics, which is launching ORLYNVAH™ in the US.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Innoviva (United States)
company in Burlingame, United States
Nothing else this week.
-
Scynexis
company in Durham, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- dailypolitical.com
- Unknown outlet